Results 81 to 90 of about 50,232 (267)

Clinical characteristics of patients on cardiac rehabilitation program after acute myocardial infarction and evaluation of proper prescribing of cardiac medication at hospital discharge [PDF]

Opšta Medicina, 2015
Introduction: Myocardial infarction is a major cause of death and disability worldwide. American College of Cardiology (ACC) and American Heart Association (AHA) have presented several guidelines for the management of patients with acute myocardial ...
Miljković Jelena
doaj   +1 more source

Sinoatrial Nodal Artery Arising from the Right Posterolateral Artery: A Rare Anatomical Variant

Methodist DeBakey Cardiovascular Journal, 2022
We discuss a case report of a 66-year-old male with no prior cardiac history who presented to the hospital with persistent hiccups and shortness of breath. Following a positive nuclear stress test and cardiac catheterization, a rare anatomical variant of
Parviz-Ali Lotfian, Arun Umesh Mahtani, Seyed Zaidi, Richard Grodman   +3 more
doaj   +1 more source

Relationship of some risk factors and symptoms in patients with acute coronary syndrome [PDF]

, 2012
Acute coronary syndrome (ACS) is one of the major causes of death in the worldwide. Clinical manifestations are different. So it's necessary to have knowledge about the types of symptoms experienced by patients with ACS. This study was performed to assay
Afshar, M.H., Bahrami, N., Beheshti, Z., Ghana, S., Haghdoost, A.A., Nazari, R., Nia, H.S., Soleimani, M.A.   +7 more
core  

Is depression a real risk factor for acute myocardial infarction mortality? A retrospective cohort study [PDF]

, 2019
Background: Depression has been associated with a higher risk of cardiovascular events and a higher mortality in patients with one or more comorbidities.
Baldo, V., Baldovin, T., Bertoncello, C., Buja, A., Casale, P., Cocchio, S., Fonzo, M., Furlan, P.   +7 more
core   +1 more source

Population Pharmacokinetics of Ticagrelor during Veno‐Arterial ECMO in Acute Coronary Syndrome: Model‐Informed Dosing Simulations

Clinical Pharmacology &Therapeutics, EarlyView.
Although patients with acute coronary syndrome supported by veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) have a high risk of thrombosis and bleeding, antiplatelet pharmacology in this setting is not well defined. This prospective observational study investigated the population pharmacokinetics of ticagrelor and its active metabolite AR ...
Soyoung Kang, Kyoung Lok Min, Seungwon Yang, Jongsung Hahn, Dasohm Kim, Byung Hak Jin, Soon Uk Chae, Soo Kyung Bae, Jin Wi, Min Jung Chang   +9 more
wiley   +1 more source

Differences in symptoms and pre-hospital delay among acute myocardial infarction patients according to ST-segment elevation on electrocardiogram: an analysis of China Acute Myocardial Infarction (CAMI) registry

Chinese Medical Journal, 2019
. Background:. Approximately 70% patients with acute myocardial infarction (AMI) presented without ST-segment elevation on electrocardiogram. Patients with non-ST segment elevation myocardial infarction (NSTEMI) often presented with atypical symptoms ...
Rui Fu, Chen-Xi Song, Ke-Fei Dou, Jin-Gang Yang, Hai-Yan Xu, Xiao-Jin Gao, Qian-Qian Liu, Han Xu, Yue-Jin Yang, Yi Cui   +9 more
doaj   +1 more source

Metabolism of ticagrelor in patients with acute coronary syndromes. [PDF]

, 2018
© The Author(s) 2018Ticagrelor is a state-of-the-art antiplatelet agent used for the treatment of patients with acute coronary syndromes (ACS). Unlike remaining oral P2Y12 receptor inhibitors ticagrelor does not require metabolic activation to exert its ...
B Ibanez, C Varenhorst, D Alexopoulos, D Aradi, D Lindholm, D Zhou, EA Amsterdam, F Franchi, G Parodi, G Parodi, H Sillén, HS Smith, J Kubica, J Kubica, J Li, JH Cornel, JM Siller-Matula, K Butler, K Butler, K Thygesen, M Koziński, M Roffi, P Adamski, P Adamski, P Adamski, P Adamski, P Niezgoda, P Niezgoda, PG Steg, PG Steg, PT O’Gara, R Teng, R Teng, R Teng, R Teng, R Teng, R Teng, RA Lange, S Husted, S James, SE Husted, SS Brar   +41 more
core   +2 more sources

Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)

Metabolites, 2020
The present study explored patterns of circulating metabolites and proteins that can predict future risk for ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI).
Elin Chorell, T. Olsson, J. Jansson, P. Wennberg   +3 more
semanticscholar   +1 more source

Early revascularization in elderly with nstemi

European Heart Journal, 2020
Abstract Objective This study sought to analyse the association of early coronary intervention with poor outcomes in patients ≥75 years with NSTEMI. Methods This retrospective observational study included 7811 NSTEMI patients between ...
T Gonzalez Ferrero, B.A.A Alvarez Alvarez, C.C.A Cacho Antonio, M.P.D Perez Dominguez, C.A.J.C Abou Jokh, P.R.V Rigueiro Veloso, R.A.B Agra Bermejo, J.M.G.A Garcia Acuna, J.R.G.J Gonzalez Juanatey   +8 more
openaire   +1 more source

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source